Literature DB >> 32524661

Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patients.

Jessica Vazquez1, Melina Chavarria1, Gladys E Lopez1, Mildred A Felder1, Arvinder Kapur1, Antonio Romo Chavez1, Nathan Karst1, Lisa Barroilhet1, Manish S Patankar1, Aleksandar K Stanic1.   

Abstract

PROBLEM: We hypothesize that activated peritoneal immune cells can be redirected to target ovarian tumors. Here, we obtain fundamental knowledge of the peritoneal immune environment through deep immunophenotyping of T cells, dendritic cells (DC), and innate lymphoid cells (ILC) of ovarian cancer patients. METHOD OF STUDY: T cells, DC, and ILC from ascites of ovarian cancer patients (n = 15) and peripheral blood of post-menopausal healthy donors (n = 6) were immunophenotyped on a BD Fortessa cytometer using three panels-each composed of 16 antibodies. The data were analyzed manually and by t-SNE/DensVM. CA125 levels were obtained from patient charts.
RESULTS: We observed decreased CD3+ T cells and a higher proportion of activated CD4+ and effector memory CD4+ /CD8+ T cells, plasmacytoid DC, CD1c+ and CD141+ myeloid DC and CD56Hi NK cells in ascites. t-SNE/DensVM identified eight T cell, 17 DC, and 17 ILC clusters that were unique in the ascites compared to controls. Hierarchical clustering of cell frequency distinctly segregated the T-cell and ILC clusters from controls. Increased CA125 levels were associated with decreased CD8+ /CD45RA+ /CD45RO- /CCR7- T cells.
CONCLUSION: The identified immune clusters serve as the basis for interrogation of the peritoneal immune environment and the development of novel immunologic modalities against ovarian cancer.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CA125; CD8 T cells; Immunophenotyping; ascites; dendritic cells; innate lymphoid cells; ovarian cancer; peritoneal fluid

Year:  2020        PMID: 32524661      PMCID: PMC7754790          DOI: 10.1111/aji.13284

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  32 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

2.  The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma.

Authors:  G B Feldman; R C Knapp; S E Order; S Hellman
Journal:  Cancer Res       Date:  1972-08       Impact factor: 12.701

3.  Computational flow cytometry analysis reveals a unique immune signature of the human maternal-fetal interface.

Authors:  Jessica Vazquez; Melina Chavarria; Yan Li; Gladys E Lopez; Aleksandar K Stanic
Journal:  Am J Reprod Immunol       Date:  2017-10-14       Impact factor: 3.886

Review 4.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

5.  Mapping the Diversity of Follicular Helper T Cells in Human Blood and Tonsils Using High-Dimensional Mass Cytometry Analysis.

Authors:  Michael T Wong; Jinmiao Chen; Sriram Narayanan; Wenyu Lin; Rosslyn Anicete; Henry Tan Kun Kiaang; Maria Alicia Curotto De Lafaille; Michael Poidinger; Evan W Newell
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

6.  Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

Authors:  Manish S Patankar; Yu Jing; Jamie C Morrison; Jennifer A Belisle; Frank A Lattanzio; Yuping Deng; Nyet Kui Wong; Howard R Morris; Anne Dell; Gary F Clark
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

7.  Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.

Authors:  David Milliken; Chris Scotton; Shanti Raju; Fran Balkwill; Julia Wilson
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

8.  Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

Authors:  Yuzuru Ikehara; Sanae Kabata Ikehara; James C Paulson
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

9.  Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).

Authors:  Jennifer A Belisle; Jennifer A A Gubbels; Cara A Raphael; Martine Migneault; Claudine Rancourt; Joseph P Connor; Manish S Patankar
Journal:  Immunology       Date:  2007-07-06       Impact factor: 7.397

10.  Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.

Authors:  Christina Wefers; Tjitske Duiveman-de Boer; Refika Yigit; Petra L M Zusterzeel; Anne M van Altena; Leon F A G Massuger; I Jolanda M De Vries
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

View more
  3 in total

1.  Multiparameter Flow Cytometry for Detailed Characterization of Peritoneal Immune Cells from Patients with Ovarian Cancer.

Authors:  Jessica Vazquez; Dagna Sheerar; Aleksandar K Stanic; Manish S Patankar
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.

Authors:  Militsa Rakina; Anna Kazakova; Alisa Villert; Larisa Kolomiets; Irina Larionova
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 3.  Dendritic Cell Vaccines in Ovarian Cancer.

Authors:  Xi Zhang; Tianhui He; Yuan Li; Ling Chen; Hongyu Liu; Yu Wu; Hongyan Guo
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.